表紙:ジフェンヒドラミンの世界市場:2021年~2028年
市場調査レポート
商品コード
973578

ジフェンヒドラミンの世界市場:2021年~2028年

Global Diphenhydramine Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
ジフェンヒドラミンの世界市場:2021年~2028年
出版日: 2021年07月07日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

アレルギーの症例数の急増が、ジフェンヒドラミンの需要を増加させると予想され、予測期間中における市場の高い成長につながります。

当レポートでは、世界のジフェンヒドラミン市場について調査分析し、業界分析、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 世界のジフェンヒドラミン市場:調査手法と範囲

第2章 世界のジフェンヒドラミン市場:市場定義と概要

第3章 世界のジフェンヒドラミン市場:エグゼクティブサマリー

第4章 世界のジフェンヒドラミン市場:市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 世界のジフェンヒドラミン市場:業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界のジフェンヒドラミン市場:COVID-19分析

  • 市場に対するCOVID-19の分析
  • COVID-19における価格動向
  • 需給スペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界のジフェンヒドラミン市場:剤形別

  • イントロダクション
  • 剤形セグメント別の市場規模分析・前年比成長率分析
  • 剤形セグメント別の市場魅力指数
    • 錠剤
    • 注射
    • 粉末
    • シロップ

第8章 世界のジフェンヒドラミン市場:適応別

  • イントロダクション
  • 適応別の市場規模分析・前年比成長率分析
  • 適応別の市場魅力指数
    • アレルギー
    • 不眠症
    • 風邪
    • 吐き気
    • その他

第9章 世界のジフェンヒドラミン市場:流通チャネル別

  • イントロダクション
  • 流通チャネルセグメント別の市場規模分析・前年比成長率分析
  • 流通チャネルセグメント別の市場魅力指数
    • 病院薬局
    • 薬局
    • その他

第10章 世界のジフェンヒドラミン市場:地域別

  • イントロダクション
  • 地域別の市場規模分析・前年比成長率分析
  • 地域別の市場魅力指数
  • 北米
  • 欧州
  • 南米
  • アジア太平洋地域
  • 中東・アフリカ

第11章 世界のジフェンヒドラミン市場:競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • M&A分析

第12章 世界のジフェンヒドラミン市場:企業プロファイル

  • Thermo Fisher Scientific Inc
  • Cardinal Health
  • Pharmaceutical Associated
  • Bayer AG
  • Pfizer Inc.
  • Johnson & Johnson
  • Cigna
  • RemedyLabs
  • Fresenius Kabi. Ltd
  • GlaxoSmithKline plc

第13章 世界のジフェンヒドラミン市場:重要考察

第14章 世界のジフェンヒドラミン市場:DataM

目次
Product Code: DMHC2848

Market Overview

The global diphenhydramine market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Diphenhydramine is an antihistamine that reduces the effects of natural chemical histamine in the body. Diphenhydramine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Diphenhydramine is also used to treat motion sickness, to induce sleep, and to treat certain symptoms of Parkinson's disease.

Market Dynamics

The global diphenhydramine market market growth is driven by the increasing levels of indoor and outdoor pollution, changing lifestyle, poor dietary habits, and rapid urbanization across the world. These factors are driving the growth of the market across the world.

The rising cases of allergies are expected to increase the demand in the forecast period

The rising cases of allergies are expected to increase the demand for diphenhydramine, leading to the high growth of the market over the forecast period. According to the International Study of Asthma and Allergies in Childhood (ISAAC), about 22.1% of young children aged between 13 and 14 years are affected by hay fever, which was globally published in World Allergy Week 2016 fact sheet.

As per the data published by the American College of Allergy, Asthma & Immunology, allergies are the sixth leading cause of chronic illness in the United States, with an annual cost in excess of USD 18 billion, and more than 50 million Americans suffer from allergies each year. There is an increase in the number of people suffering from food allergies among both children and adults, globally. Hence, the increasing burden of allergic diseases is expected to aid the demand for diphenhydramine market.

Increasing demand for self-medication expected to drive the market growth

There is a gradual demand for self-medication among the masses, owing to the advantage of getting quicker relief and economical treatment at the same time. Diphenhydramine work well for treating allergic rhinitis. They are only available with a prescription. Diphenhydramine are medicines that help dry up a runny or stuffy nose. They come as pills, capsules. The gradual acceptance of these products have encouraged key players like Johnson & Johnson to launch new products for self service.

High investment costs in R&D is likely to hinder the market growth

However, this medication may cause blurred vision and may impair thinking or reactions. Taking this medicine with other drugs that make sleepy or slow breathing can worsen these effects. Thus, these sideeffects make patient to avoid them which in turn hinder the market growth.

COVID-19 Impact Analysis

The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations. Thus the growing prevalence of allergy due to the outbreak is driving the growth of the market.

Segment Analysis

Allergies segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Diphenhydramine is used for the treatment of allergies, and it is first line of therapy for the same. Increasing levels of indoor and outdoor pollution, changing lifestyle, poor dietary habits, and rapid urbanization across the world are few of the factors due to which patients suffering from allergies are rapidly increasing. As per the International Study of Asthma and Allergies in Childhood (ISAAC), 22.1% of children of age 13- and 14-years experienced hay fever. This high incidence of the targeted patient pool result in propelling the market to a certain extent.

Rising investment patterns in allergy drug development by the manufacturers and research and development of novel allergy immunotherapy (AIT) is expected to further enhance the overall market in the forecast period.

The hospital pharmacy are expected to dominate the diphenhydramine market during the forecast period

The hospital pharmacies held the largest share in the diphenhydramine market. This is mainly owing to increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.

Geographical Analysis

North America region holds the largest market share global diphenhydramine market

North America region is dominating the global diphenhydramine market accounted for the largest market share in 2019. As per the data published by the American College of Allergy, Asthma, & Immunology, allergies are the 6th leading cause of chronic illness in the United States, and every year, more than 50 million Americans suffer from allergies. Thus, the increasing burden of allergic diseases is expected to aid the demand for diphenhydramine drugs and further propel the growth of the market in this region. Moreover, the increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The diphenhydramine market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Thermo Fisher Scientific Inc., Cardinal Health, Pharmaceutical Associated, Bayer AG, Pfizer Inc., Johnson & Johnson, Cigna, Remedy Labs, and Fresenius Kabi. Among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the diphenhydramine market globally.

Thermo Fisher Scientific Inc.

Overview: Founded in 2006 and is headquartered at Waltham, Massachusetts, the U.S.; Thermo Fisher Scientific Inc. is engaged in providing analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery, and diagnostics services under the brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services worldwide. The company operates through four business segments, namely, Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Services. The company provides oligonucleotide products through Invitrogen, under life Sciences solutions business segment.

With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Product Portfolio: The Company's portfolio comprised its lead Iodine-Water-Pyridine-Tetrahydrofuran Oxidizer Solution (0.02 M), Trifluoroacetic Acid (TFA) Neat Liquid, in addition to Trichloroacetic Acid Dichloromethane, Deblocking Solution targeting high-performance reagents begin with raw materials that must conform to strict specifications.

Why Purchase the Report?

  • Visualize the composition of the diphenhydramine market segmentation by dosage forms, application, distribution channel, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in diphenhydramine market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of diphenhydramine market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global diphenhydramine market report would provide an access to an approx. 62 market data table, 55 figures and 240 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Diphenhydramine Market - By Dosage Forms

  • Tablets
  • Injection
  • Powder
  • Syrups

Global Diphenhydramine Market -By Application

  • Allergies
  • Insomnia
  • Cold
  • Nausea
  • Other

Global Diphenhydramine Market - By Distribution Channel

  • Hospital Pharmacy
  • Pharmacy Stores
  • Other

Global Antiviral Drugs Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Diphenhydramine Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Diphenhydramine Market - Market Definition and Overview

3. Global Diphenhydramine Market - Executive Summary

  • 3.1. Market Snippet by Dosage Forms
  • 3.2. Market snippet by Application
  • 3.3. Market Snippet by Distribution Channel
  • 3.4. Market Snippet by Region

4. Global Diphenhydramine Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing number of allergic population
      • 4.1.1.2. Increasing R&D expenditure
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects of drug will hamper the market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Diphenhydramine Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Diphenhydramine Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Diphenhydramine Market - By Dosage Forms

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms Segment
    • 7.1.2. Market Attractiveness Index, By Dosage Forms Segment
  • 7.2. Tablets *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Injection
  • 7.4. Powder
  • 7.5. Syrups

8. Global Diphenhydramine Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Allergies *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Insomnia
  • 8.4. Cold
  • 8.5. Nausea
  • 8.6. Other

9. Global Diphenhydramine Market - By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
    • 9.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 9.2. Hospital Pharmacy *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Pharmacy Stores
  • 9.4. Other

10. Global Diphenhydramine Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6.
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Forms
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Global Diphenhydramine Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Diphenhydramine Market- Company Profiles

  • 12.1. Thermo Fisher Scientific Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cardinal Health
  • 12.3. Pharmaceutical Associated
  • 12.4. Bayer AG
  • 12.5. Pfizer Inc.
  • 12.6. Johnson & Johnson
  • 12.7. Cigna
  • 12.8. RemedyLabs
  • 12.9. Fresenius Kabi. Ltd
  • 12.10. GlaxoSmithKline plc

LIST NOT EXHAUSTIVE

13. Global Diphenhydramine Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us